Cargando…
Increasing childhood vaccination coverage of the refugee and migrant population in Greece through the European programme PHILOS, April 2017 to April 2018
After the 2016 Balkan route border closures, vaccination of refugee children in Greece was mainly performed by non-governmental organisations. Activities varied between camps, resulting in heterogeneity of vaccination coverage (VC). In April 2017, the European programme ‘PHILOS - Emergency health re...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Centre for Disease Prevention and Control (ECDC)
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6628755/ https://www.ncbi.nlm.nih.gov/pubmed/31290391 http://dx.doi.org/10.2807/1560-7917.ES.2019.24.27.1800326 |
_version_ | 1783435012690935808 |
---|---|
author | Mellou, Kassiani Silvestros, Chrysovalantis Saranti-Papasaranti, Eirini Koustenis, Athanasios Pavlopoulou, Ioanna D. Georgakopoulou, Theano Botsi, Chryssoula Terzidis, Agapios |
author_facet | Mellou, Kassiani Silvestros, Chrysovalantis Saranti-Papasaranti, Eirini Koustenis, Athanasios Pavlopoulou, Ioanna D. Georgakopoulou, Theano Botsi, Chryssoula Terzidis, Agapios |
author_sort | Mellou, Kassiani |
collection | PubMed |
description | After the 2016 Balkan route border closures, vaccination of refugee children in Greece was mainly performed by non-governmental organisations. Activities varied between camps, resulting in heterogeneity of vaccination coverage (VC). In April 2017, the European programme ‘PHILOS - Emergency health response to refugee crisis’ took over vaccination coordination. Interventions were planned for the first time for refugee children in the community and unaccompanied minors at safe zones. From April 2017–April 2018, 57,615 vaccinations were performed against measles-mumps-rubella (MMR) (21,031), diphtheria-tetanus-pertussis (7,341), poliomyelitis (7,652), pneumococcal disease (5,938), Haemophilus influenzae type b (7,179) and hepatitis B (8,474). In April 2018, the vaccination status of children at camps (reception and identification centres and community facilities such as hostels/hotels were excluded) was recorded and VC for each disease, stratified by dose, nationality and camp size, was calculated. More than 80% of the children received the first MMR dose, with VC dropping to 45% for the second dose. For all other vaccines, VC was < 50% for the first dose in children aged 0–4 years and < 25% for the second dose. Despite challenges, PHILOS improved planning and monitoring of vaccination activities; however, further efforts towards improving VC in refugee children are needed. |
format | Online Article Text |
id | pubmed-6628755 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | European Centre for Disease Prevention and Control (ECDC) |
record_format | MEDLINE/PubMed |
spelling | pubmed-66287552019-07-31 Increasing childhood vaccination coverage of the refugee and migrant population in Greece through the European programme PHILOS, April 2017 to April 2018 Mellou, Kassiani Silvestros, Chrysovalantis Saranti-Papasaranti, Eirini Koustenis, Athanasios Pavlopoulou, Ioanna D. Georgakopoulou, Theano Botsi, Chryssoula Terzidis, Agapios Euro Surveill Perspective After the 2016 Balkan route border closures, vaccination of refugee children in Greece was mainly performed by non-governmental organisations. Activities varied between camps, resulting in heterogeneity of vaccination coverage (VC). In April 2017, the European programme ‘PHILOS - Emergency health response to refugee crisis’ took over vaccination coordination. Interventions were planned for the first time for refugee children in the community and unaccompanied minors at safe zones. From April 2017–April 2018, 57,615 vaccinations were performed against measles-mumps-rubella (MMR) (21,031), diphtheria-tetanus-pertussis (7,341), poliomyelitis (7,652), pneumococcal disease (5,938), Haemophilus influenzae type b (7,179) and hepatitis B (8,474). In April 2018, the vaccination status of children at camps (reception and identification centres and community facilities such as hostels/hotels were excluded) was recorded and VC for each disease, stratified by dose, nationality and camp size, was calculated. More than 80% of the children received the first MMR dose, with VC dropping to 45% for the second dose. For all other vaccines, VC was < 50% for the first dose in children aged 0–4 years and < 25% for the second dose. Despite challenges, PHILOS improved planning and monitoring of vaccination activities; however, further efforts towards improving VC in refugee children are needed. European Centre for Disease Prevention and Control (ECDC) 2019-07-04 /pmc/articles/PMC6628755/ /pubmed/31290391 http://dx.doi.org/10.2807/1560-7917.ES.2019.24.27.1800326 Text en This article is copyright of the authors or their affiliated institutions, 2019. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made. |
spellingShingle | Perspective Mellou, Kassiani Silvestros, Chrysovalantis Saranti-Papasaranti, Eirini Koustenis, Athanasios Pavlopoulou, Ioanna D. Georgakopoulou, Theano Botsi, Chryssoula Terzidis, Agapios Increasing childhood vaccination coverage of the refugee and migrant population in Greece through the European programme PHILOS, April 2017 to April 2018 |
title | Increasing childhood vaccination coverage of the refugee and migrant population in Greece through the European programme PHILOS, April 2017 to April 2018 |
title_full | Increasing childhood vaccination coverage of the refugee and migrant population in Greece through the European programme PHILOS, April 2017 to April 2018 |
title_fullStr | Increasing childhood vaccination coverage of the refugee and migrant population in Greece through the European programme PHILOS, April 2017 to April 2018 |
title_full_unstemmed | Increasing childhood vaccination coverage of the refugee and migrant population in Greece through the European programme PHILOS, April 2017 to April 2018 |
title_short | Increasing childhood vaccination coverage of the refugee and migrant population in Greece through the European programme PHILOS, April 2017 to April 2018 |
title_sort | increasing childhood vaccination coverage of the refugee and migrant population in greece through the european programme philos, april 2017 to april 2018 |
topic | Perspective |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6628755/ https://www.ncbi.nlm.nih.gov/pubmed/31290391 http://dx.doi.org/10.2807/1560-7917.ES.2019.24.27.1800326 |
work_keys_str_mv | AT melloukassiani increasingchildhoodvaccinationcoverageoftherefugeeandmigrantpopulationingreecethroughtheeuropeanprogrammephilosapril2017toapril2018 AT silvestroschrysovalantis increasingchildhoodvaccinationcoverageoftherefugeeandmigrantpopulationingreecethroughtheeuropeanprogrammephilosapril2017toapril2018 AT sarantipapasarantieirini increasingchildhoodvaccinationcoverageoftherefugeeandmigrantpopulationingreecethroughtheeuropeanprogrammephilosapril2017toapril2018 AT koustenisathanasios increasingchildhoodvaccinationcoverageoftherefugeeandmigrantpopulationingreecethroughtheeuropeanprogrammephilosapril2017toapril2018 AT pavlopoulouioannad increasingchildhoodvaccinationcoverageoftherefugeeandmigrantpopulationingreecethroughtheeuropeanprogrammephilosapril2017toapril2018 AT georgakopouloutheano increasingchildhoodvaccinationcoverageoftherefugeeandmigrantpopulationingreecethroughtheeuropeanprogrammephilosapril2017toapril2018 AT botsichryssoula increasingchildhoodvaccinationcoverageoftherefugeeandmigrantpopulationingreecethroughtheeuropeanprogrammephilosapril2017toapril2018 AT terzidisagapios increasingchildhoodvaccinationcoverageoftherefugeeandmigrantpopulationingreecethroughtheeuropeanprogrammephilosapril2017toapril2018 |